Policy implications of mandatory systemic immunosuppressant trials prior to dupilumab for pediatric atopic dermatitis in Taiwan.
Saved in:
| Title: | Policy implications of mandatory systemic immunosuppressant trials prior to dupilumab for pediatric atopic dermatitis in Taiwan. |
|---|---|
| Authors: | Chen HY; School of Medicine, China Medical University, Taichung, Taiwan., Liao JC; School of Medicine, China Medical University, Taichung, Taiwan., Shih PC; Division of Allergy, Immunology, Rheumatology, Changhua Christian Hospital, Changhua, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan., Yong SB; Department of Allergy and Immunology, China Medical University Children's Hospital, Taichung, Taiwan.; Research Center for Allergy, Immunology, and Microbiome (A.I.M.), China Medical University Hospital, Taichung, Taiwan., Li CJ; Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; Institute of Biopharmaceutical Sciences, National Sun Yatsen University, Kaohsiung, Taiwan. |
| Source: | Frontiers in pediatrics [Front Pediatr] 2026 Mar 31; Vol. 14, pp. 1767209. Date of Electronic Publication: 2026 Mar 31 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101615492 Publication Model: eCollection Cited Medium: Print ISSN: 2296-2360 (Print) Linking ISSN: 22962360 NLM ISO Abbreviation: Front Pediatr Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
